K. Wills

发表

Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment.

M. Ramachandra, M. Vaillancourt, B. Sugarman, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Intratumoral Spread and Increased Efficacy of a p53-VP22 Fusion Protein Expressed by a Recombinant Adenovirus

M. Vaillancourt, Duane E. Johnson, I. Atencio, 2001, Journal of Virology.

Cyclin D-CDK Subunit Arrangement Is Dependent on the Availability of Competing INK4 and p21 Class Inhibitors

E. Lees, K. Wills, D. Parry, 1999, Molecular and Cellular Biology.

Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.

H. Shepard, D. Johnson, S. Sutjipto, 1996, Cancer gene therapy.

Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.

I. W. Cheney, S. Tavtigian, G. Demers, 1998, Cancer research.

Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens.

K. Wills, B. Tennant, A. Luxembourg, 2008, Vaccine.

p53 gene therapy in vivo of herpatocellular and liver metastatic colorectal cancer.

R. Bookstein, K. Wills, D. Maneval, 1996, Seminars in oncology.

Adenovirus‐mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo

M. Westphal, H. Shepard, S. Sutjipto, 1996, International journal of cancer.

Thyroid hormone receptors repress estrogen receptor activation of a TRE.

M. Pfahl, M. Tzukerman, K. Wills, 1991, Molecular endocrinology.

Advances in Brief Rb Functions to Inhibit Apoptosis during Myocyte Differentiation 1

K. Wills, K. Walsh, K. Guo, 2006 .

Rb functions to inhibit apoptosis during myocyte differentiation.

K. Wills, K. Walsh, K. Guo, 1997, Cancer research.

Regulatory functions of a non-ligand-binding thyroid hormone receptor isoform.

M. Pfahl, M. Tzukerman, K. Wills, 1991, Cell regulation.

Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity

M. Pfahl, M. Tzukerman, K. Wills, 1989, Nature.

Ligand-binding domain of thyroid hormone receptors modulates DNA binding and determines their bifunctional roles.

M. Pfahl, M. Tzukerman, K. Wills, 1991, The New biologist.

Coordinate expression of functionally distinct thyroid hormone receptor alpha isoforms during neonatal brain development.

M. Pfahl, K. Wills, X. Zhang, 1991, Molecular endocrinology.

Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo

R. Bookstein, J. Avanzini, L. Nielsen, 2001, Cancer Gene Therapy.

Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.

K. Wills, T. Machemer, D. Maneval, 1995, Cancer gene therapy.

Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities

M. Pfahl, K. Wills, M. Husmann, 1991, Molecular and cellular biology.

Restoration of transforming growth factor Beta signaling by functional expression of smad4 induces anoikis.

M. Ramachandra, A. Rahman, A. Zou, 2002, Cancer research.

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer.

H. Shepard, M. Vaillancourt, Duane E. Johnson, 1994, Human gene therapy.

Interferon α2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers

G. Demers, J. Howe, B. Sugarman, 2001, Cancer Gene Therapy.

In vivo tumor suppression by adenovirus-mediated interferon alpha2b gene delivery.

B. Sugarman, R. Bookstein, D. Johnson, 1999, Human gene therapy.

p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus.

H. Shepard, H. Engler, Duane E. Johnson, 1998, Clinical Cancer Research.

Nuclear retinoic acid receptors: cloning, analysis, and function.

J. Lehmann, M. Pfahl, M. Tzukerman, 1990, Methods in enzymology.

Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude mice.

M. Ramachandra, J. Howe, B. Sugarman, 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectors.

M. Ramachandra, J. Howe, D. Antelman, 2006, Virology.

The human estrogen receptor has transcriptional activator and repressor functions in the absence of ligand.

M. Pfahl, M. Tzukerman, K. Wills, 1990, The New biologist.

Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.

Joseph, Vaillancourt, S. Tavtigian, 1998, Cancer research.

Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.

S. Tavtigian, M. Vaillancourt, Duane E. Johnson, 1998, Cancer research.